English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 858494 Online Users : 522
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
Institute of Molecular and Genomic Medicine
Institute of Biotechnology and Pharmaceutical Research
Institute of Biomedical Engineering and Nanomedicine
Immunology Research Center
Center for Neuropsychiatric Research
Institute of Cellular and Systems Medicine
National Institute of Infectious Diseases and Vaccinology
Institute of Population Health Sciences
National Institute of Cancer Research
National Institute of Environmental Health Sciences
National Mosquito-Borne Diseases Control Research Center
National Center for Geriatrics and Welfare Research
Forum
Center of Biomedical Resource
NHRI Graduate Student Program
Core Instrument Center
Pathology Core Laboratory
Laboratory Animal Center
Administrative Units
圖書館
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
NHRI
>
Items for Author
Loading...
Category
Loading community tree, please wait....
Year
Loading year class tree, please wait....
Items for Author "Zotkiewicz, M"
Return to Browse by Author
Showing 4 items.
Collection
Date
Title
Relation
Bitstream
[陳立宗] 會議論文/會議摘要
2022-11
Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in patients (pts) with advanced biliary tract cancer (BTC)
-
[陳立宗] 期刊論文
2023-07
Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in patients (pts) with advanced biliary tract cancer (BTC) [Erratum:Annals of Oncology. 2022 Nov;33(Suppl. 9):S1462
-
[陳立宗] 期刊論文
2023-11
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer
-
[陳立宗] 期刊論文
2024-08
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): Updated overall survival from a randomised phase 3 study
-
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback
